Literature DB >> 14212121

IMMUNOFLUORESCENT STUDIES OF ADENOVIRUS 12 TUMORS AND OF CELLS TRANSFORMED OR INFECTED BY ADENOVIRUSES.

J H POPE, W P ROWE.   

Abstract

Complement-fixing (CF) antibody-positive sera from hamsters bearing adenovirus type 12 (Ad. 12)-induced tumors revealed specific immunofluorescent stainable antigens in essentially all Ad. 12 hamster tumor cells. The antigens were primarily in the form of cytoplasmic flecks; less frequent staining was seen as nuclear flecks or homogeneous staining of nucleus and cytoplasm of a small proportion of cells. Tumor cells did not stain with rabbit antisera to crude Ad. 12 virus or A and C antigens. The hamster serum also stained cytoplasmic flecks in an Ad. 12-induced BALB/c mouse tumor and Ad. 12-"transformed" hamster embryo tissue culture cells. The hamster serum also stained fleck-shaped antigens in hamster and human cell cultures inoculated with homologous and heterologous adenovirus types, although the hamster cells did not react with the rabbit Ad. 12 antiserum. Attempts to identify the fluorescent-stainable fleck-shaped antigens indicated that they are not previously recognized viral antigens and that the cytoplasmic antigens formed in hamster cell cultures inoculated with Ad. 12 are different from those in tumors and in acutely infected human cell cultures.

Entities:  

Keywords:  ADENOVIRUS INFECTIONS; CELL NUCLEUS; COMPLEMENT FIXATION TESTS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIC; HAMSTERS; MICE; NEOPLASM IMMUNOLOGY; NEOPLASMS, EXPERIMENTAL; ONCOGENIC VIRUSES; TISSUE CULTURE

Mesh:

Substances:

Year:  1964        PMID: 14212121      PMCID: PMC2137773          DOI: 10.1084/jem.120.4.577

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  IN VITRO TRANSFORMATION OF HAMSTER KIDNEY CELLS BY HUMAN ADENOVIRUS TYPE 12.

Authors:  W D MCBRIDE; A WIENER
Journal:  Proc Soc Exp Biol Med       Date:  1964-04

2.  PRODUCTION OF TYPE-SPECIFIC C ANTIGEN IN VIRUS-FREE HAMSTER TUMOR CELLS INDUCED BY ADENOVIRUS TYPE 12.

Authors:  R J HUEBNER; H G PEREIRA; A C ALLISON; A C HOLLINSHEAD; H C TURNER
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

3.  SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS.

Authors:  R J HUEBNER; W P ROWE; H C TURNER; W T LANE
Journal:  Proc Natl Acad Sci U S A       Date:  1963-08       Impact factor: 11.205

4.  TUMORS PRODUCED BY ADENOVIRUS 12 IN MASTOMYS AND MICE.

Authors:  A S RABSON; R L KIRSCHSTEIN; F J PAUL
Journal:  J Natl Cancer Inst       Date:  1964-01       Impact factor: 13.506

5.  Oncogenic effects in hamsters of human adenovirus types 12 and 18.

Authors:  R J HUEBNER; W P ROWE; W T LANE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

6.  Serotype composition of the adenovirus group.

Authors:  W P ROWE; J W HARTLEY; R J HUEBNER
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

7.  Typing of adenoidal-pharyngeal-conjunctival (APC) viruses by complement-fixation.

Authors:  H G PEREIRA
Journal:  J Pathol Bacteriol       Date:  1956-07

8.  The quest for human cancer viruses.

Authors:  J J TRENTIN; Y YABE; G TAYLOR
Journal:  Science       Date:  1962-09-14       Impact factor: 47.728

9.  DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCE.

Authors:  J H POPE; W P ROWE
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

10.  Sequential cellular changes produced by types 5 and 7 adenoviruses in HeLa cells and in human amniotic cells; cytological studies aided by fluorescein-labelled antibody.

Authors:  G S BOYER; F W DENNY; H S GINSBERG
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

  10 in total
  70 in total

1.  Transcription of the genome of adenovirus type 12. I. Viral mRNA in abortively infected and transformed cells.

Authors:  J Ortin; W Doerfler
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  EVIDENCE FOR A POSSIBLE GENETIC HYBRID BETWEEN ADENOVIRUS TYPE 7 AND SV40 VIRUSES.

Authors:  W P ROWE; S G BAUM
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  The presence of antibodies in human serum to early (T) adenovirus antigens.

Authors:  A M Lewis; W H Wiese; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1967-03       Impact factor: 11.205

4.  Adenovirus type 12 gene 401 function and maintenance of transformation.

Authors:  N Ledinko; J Schaeufele; O Soorma
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

5.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.

Authors:  S Kvist; L Ostberg; H Persson; L Philipson; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Complementation of adenovirus type 5 host range mutants by adenovirus type 12 in coinfected HeLa and BHK-21 cells.

Authors:  D T Rowe; F L Graham
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12.

Authors:  H O Sjögren; J Minowada; J Ankerst
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

8.  Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 E1 gene.

Authors:  K Shiroki; S Hashimoto; I Saito; Y Fukui; Y Fukui; H Kato; H Shimojo
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5.

Authors:  D T Rowe; P E Branton; S P Yee; S Bacchetti; F L Graham
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias.

Authors:  D Armstrong; G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.